The Story Of Our Firm | En Español
 Home    Lawyers   Litigation   Choose Us   Settlements   Search

Previous Investigations Other Litigations Bextra Research Center News & Warnings Drug Publications

FDA Transcript - Day 2

in this section: Participants | Call to Order | Conflict of Interest | Cardiovascular Risk | Epidemiologic Studies | Questions | Arcoxia (etoricoxib) | Etoricoxib | Lumiracoxib/Novartis | Lumiracoxib, Naproxen | Open Public Hearing | Lumiracoxib | Questions | Committee Discussion | - Discussion (cont'd)


Bookmark This Page Print This Page Email This Page

Bextra, Vioxx & Celebrex FDA Transcript

Your lawyer provides you with the complete transcript of the February 17th, 2005 joint meeting of the FDA's Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee.

We have formatted the complete transcript of the three day conference for easy of navigation to provide you with the best possible Bextra information. To contact a Bextra Lawyer, click here for a FREE case evaluation.

Contents:

Call to Order:
Alastair J.J. Wood, M.D., Chair

Conflict of Interest Statement:
Kimberly Littleton Topper, M.S.

Interpretation of Observational Studies of Cardiovascular Risk of Non-steroidal Drugs
Richard Platt, M.D., M.S.

Review of Epidemiologic Studies on Cardiovascular Risk with Selected NSAIDs
David Graham, M.D., M.P.H.

Committee Questions to Speakers

Arcoxia (etoricoxib): Merck Research Laboratories - Sponsor Presentation
Sean P. Curtis, M.D.

FDA Presentation
Joel Schiffenbauer, M.D.

Lumiracoxib: Novartis Pharmaceuticals - Sponsor Presentation
Introduction

Mathias Hukkelhoven, Ph.D.

Gastrointestinal and Cardiovascular Safety of Lumiracoxib, Ibuprofen, and Naproxen
Patrice Matchaba, M.D.

Open Public Hearing

FDA Presentation (Lumiracoxib)
Lourdes Villalba, M.D.

Committee Questions to Speakers

Committee Discussion

Go to PARTICIPANTS

Go to PROCEEDINGS

FREE Bextra Lawsuit Evaluation


Have you been injured by Celebrex? Use this

Weitz & Luxenberg is no longer accepting Bextra cases.


see also:

Arcoxia (etoricoxib) Your Bextra Side Effects Lawyer - Vioxx, Celebrex & Bextra FDA - Arcoxia (etoricoxib)
Bextra side effects lawyer - the complete transcript of the FDA meeting

Questions Your Bextra Side Effects Lawyer - Vioxx, Celebrex & Bextra FDA - Questions
Bextra side effects lawyer - the complete transcript of the FDA meeting

Letters FDA Bextra Letters - Without a Bextra recall, Bextra is still deadly
Though no Bextra recall, Bextra, these letters show, can be dangerous.

Free Legal Review:
Name:
Phone:
Email:
Case Description:



For legal help anywhere in the U.S.
Ask a Free Question:
Were you injured?

check for your response [login]
$53 million verdict — brake mechanic suffering from mesothelioma

$13.5 million verdict — one of the very first Vioxx trial cases

$15 million settlement — man wound up a paraplegic due to negligent hospital care

$37 million verdict — 2 asbestos lung cancer plaintiffs

$47 million verdict — boilermaker who died from mesothelioma

$2.6 million settlement — ill-fitting prosthesis caused decubitus ulcers

$75 million verdict — historic consolidated trial involving men who had worked at the Brooklyn Navy Yard in the 1940s and 1950s

$12.7 million verdict — iron worker who was injured due to unsafe working conditions

$8 million settlement — obstetrical malpractice resulted in neurological deficits

$64.65 million award — 4 asbestos plaintiffs

$17.5 million — consolidated trial of 5 mesothelioma victims